WO2008133982A3 - Timbre adhésif contenant un agent aversif - Google Patents

Timbre adhésif contenant un agent aversif Download PDF

Info

Publication number
WO2008133982A3
WO2008133982A3 PCT/US2008/005339 US2008005339W WO2008133982A3 WO 2008133982 A3 WO2008133982 A3 WO 2008133982A3 US 2008005339 W US2008005339 W US 2008005339W WO 2008133982 A3 WO2008133982 A3 WO 2008133982A3
Authority
WO
WIPO (PCT)
Prior art keywords
adhesive patch
aversive agent
patch
medicament
adhesive
Prior art date
Application number
PCT/US2008/005339
Other languages
English (en)
Other versions
WO2008133982A2 (fr
Inventor
David Rolf
Original Assignee
Lectec Corp
David Rolf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lectec Corp, David Rolf filed Critical Lectec Corp
Publication of WO2008133982A2 publication Critical patent/WO2008133982A2/fr
Publication of WO2008133982A3 publication Critical patent/WO2008133982A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D11/00—Component parts of measuring arrangements not specially adapted for a specific variable
    • G01D11/28—Structurally-combined illuminating devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne un timbre adhésif qui comprend un médicament et un agent aversif. Le timbre adhésif peut être un timbre transdermique, utilisable pour délivrer un médicament par voie générale ; ou peut être un timbre topique, utilisable pour délivrer localement un médicament à la surface de la peau.
PCT/US2008/005339 2007-04-27 2008-04-25 Timbre adhésif contenant un agent aversif WO2008133982A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92648307P 2007-04-27 2007-04-27
US60/926,483 2007-04-27

Publications (2)

Publication Number Publication Date
WO2008133982A2 WO2008133982A2 (fr) 2008-11-06
WO2008133982A3 true WO2008133982A3 (fr) 2009-05-07

Family

ID=39926273

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/005339 WO2008133982A2 (fr) 2007-04-27 2008-04-25 Timbre adhésif contenant un agent aversif

Country Status (1)

Country Link
WO (1) WO2008133982A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11844763B2 (en) 2014-04-17 2023-12-19 Avenir Wellness Solutions, Inc. Pharmaceutical composition and method of manufacturing

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1868628B1 (fr) 2005-04-08 2014-06-11 Chimerix, Inc. Composes, compositions et methodes de traitement des infections a poxvirus
KR20150050595A (ko) 2006-03-28 2015-05-08 자블린 파머슈티칼스 인코포레이티드 저 복용량의 디클로페낙 및 베타-사이클로덱스트린 제형
EP2254582B1 (fr) 2008-01-25 2016-01-20 Chimerix, Inc. Méthodes de traitement d'infections virales
EP2432450B1 (fr) * 2009-05-22 2019-07-31 Wyeth LLC Bande jetable à usage unique pour application de compositions topiques
WO2011011519A1 (fr) 2009-07-21 2011-01-27 Chimerix, Inc. Composés, compositions et procédés pour traiter des troubles oculaires
EP2476414B1 (fr) 2009-09-07 2015-03-04 NIPRO Patch Co., Ltd. Préparation absorbable par voie transdermique
GB0917086D0 (en) * 2009-09-29 2009-11-11 Union Of Agricultural Cooperat Compositon of botanical extracts and their use
US9006218B2 (en) 2010-02-12 2015-04-14 Chimerix Inc. Nucleoside phosphonate salts
US20110293681A1 (en) * 2010-02-26 2011-12-01 Lectec Corporation Hand sanitizing patch having an integrally bonded antimicrobial
EP2563367A4 (fr) 2010-04-26 2013-12-04 Chimerix Inc Méthodes de traitement d'infections rétrovirales et régimes posologiques associés
NZ587634A (en) * 2010-08-27 2013-10-25 Rato Health Ltd Transdermal Patch
SG11201400167VA (en) * 2011-08-25 2014-06-27 Nipro Patch Co Ltd Hydrous adhesive skin patch
CN103040090B (zh) * 2012-01-20 2016-03-30 奥驰亚客户服务公司 脱除烟草的口腔用产品
CA2861995C (fr) * 2012-01-20 2021-10-26 Altria Client Services Inc. Produit buccal renfermant une matrice de polymere stable en bouche et des fibres
CN103040089B (zh) * 2012-01-20 2016-08-17 奥驰亚客户服务公司 口腔用产品
CN102754907B (zh) 2012-01-20 2015-06-24 奥驰亚客户服务公司 口腔用产品
US9854831B2 (en) 2012-01-20 2018-01-02 Altria Client Services Llc Oral product
CN103039688B (zh) 2012-01-20 2016-01-06 奥驰亚客户服务公司 口腔用产品
CN102754908B (zh) 2012-01-20 2015-06-10 奥驰亚客户服务公司 口腔用烟草产品
FR2992560B1 (fr) * 2012-07-02 2015-10-02 Oreal Utilisation comme agent antipelliculaire d'une huile essentielle d'origan marjolaine, procede de traitement et composition la comprenant
DE102012212281B3 (de) 2012-07-13 2013-10-31 Schülke & Mayr GmbH Mischung von natürlichen bzw. naturidentischen Alkoholen mit verbesserter Wirksamkeit
CN103230442B (zh) * 2013-04-25 2015-01-07 东阳市人民医院 一种治疗肿痛的苍耳虫外用药物组合物及其制备方法
MX2013005405A (es) * 2013-05-14 2014-11-20 Abert Pla Andreu Una composicion a base de aceites naturales para aplicarse sobre el papel higienico que coadyuva con la sanitizacion posterior a la defecacion con un efecto astringente, analgesico, humectante, desinfectante y anticeptico para personas con hemorroides o para personas sin hemorroides, el procedimiento de fabricacion y usos.
US20160263173A1 (en) * 2013-10-28 2016-09-15 Atp Institute Pty Ltd Pain relief formulation and method of treatment
RU2700926C2 (ru) * 2014-01-22 2019-09-24 4П Терапьютикс Трансдермальные системы, предотвращающие злоупотребление и неправильное употребление
US9186386B2 (en) 2014-04-17 2015-11-17 Gary J. Speier Pharmaceutical composition and method of manufacturing
CN103976988A (zh) * 2014-05-26 2014-08-13 中国药科大学 左旋薄荷酮在制备抗抑郁药物中的应用
ES2970434T3 (es) 2014-09-12 2024-05-28 Union Therapeutics As Uso antibacteriano de salicilanilidas halogenadas
CN104664376A (zh) * 2015-02-11 2015-06-03 化州市佰亿化橘红科技有限公司 一种松针花果组合物
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
FR3037500A1 (fr) * 2015-06-19 2016-12-23 Kala Karite Composition chimique pour dermite
US11622929B2 (en) 2016-03-08 2023-04-11 Living Proof, Inc. Long lasting cosmetic compositions
CN106085661A (zh) * 2016-06-16 2016-11-09 广西南宁诺尔网络通讯技术有限公司 一种防蚊虫手工皂及其制作方法
US20190374552A1 (en) * 2016-11-02 2019-12-12 George Edward Hoag Multifunctional formulations and methods to control dermatitis and pruritus
CN106692112B (zh) * 2016-12-06 2019-07-16 湘潭大学 一种治疗局部软组织炎症疼痛的马钱子碱贴剂
KR101880442B1 (ko) * 2017-02-02 2018-07-23 대구한의대학교산학협력단 혈압 강하용 패치 조성물
DE102017110405A1 (de) * 2017-05-12 2018-11-15 Msf Medizinische Sportwerke Frankfurt Gmbh Ölige Pflanzenextrakte enthaltende Elemente und Pflaster, die derartige wirkstoffhaltige Elemente enthalten
CN107335058B (zh) * 2017-07-31 2021-01-08 暨南大学 一种2,6-二取代吡啶-4-硫代甲酰胺的新用途
CA3074845A1 (fr) 2017-09-13 2019-03-21 Living Proof, Inc. Compositions de protection de couleur
WO2019055440A1 (fr) 2017-09-13 2019-03-21 Living Proof, Inc. Compositions cosmétiques longue durée
CN107916186A (zh) * 2017-11-16 2018-04-17 东兴市良佳优农林科技有限公司 含柠檬香茅提取物精油皂及其制备方法
CN108403573A (zh) * 2018-06-07 2018-08-17 广州宫森生物科技有限公司 一种祛痘原液的制备方法
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
US20200338016A1 (en) * 2019-04-26 2020-10-29 Mark Edward Fenzl Combination broad-spectrum antibiotic preparations for drug-resistant pathogens
US20210000754A1 (en) * 2019-07-02 2021-01-07 Clifford T. Rowley Transdermal patch providing improved permeability and composition
US20210059955A1 (en) * 2019-08-26 2021-03-04 RL Patents, LLC Systems and methods for decrystallization of uric acid
CN111187367B (zh) * 2020-01-07 2022-02-25 江苏省农业科学院 一种脲甲醛改性海藻酸钠共聚物及其应用
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
CN112646558B (zh) * 2020-12-18 2022-08-16 成都劳恩普斯科技有限公司 页岩气管线专用生态安全杀菌缓蚀剂及其制备方法
CN114767871B (zh) * 2022-04-19 2023-04-07 中国工程物理研究院机械制造工艺研究所 介孔硅载药体系及制备方法和介孔硅载药

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068138A2 (fr) * 2000-03-10 2001-09-20 Epicept, Inc. Agents de penetration intradermique pour administration locale topique d'anesthesiant
US20040109886A1 (en) * 2002-08-27 2004-06-10 Larry Rigby Methods and apparatus for transdermal delivery of abusable drugs with a deterrent agent
WO2004062600A2 (fr) * 2003-01-08 2004-07-29 Lectec Corporation Patch antiviral
US20040228802A1 (en) * 2003-05-12 2004-11-18 Rong-Kun Chang Drug formulations having reduced abuse potential

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068138A2 (fr) * 2000-03-10 2001-09-20 Epicept, Inc. Agents de penetration intradermique pour administration locale topique d'anesthesiant
US20040109886A1 (en) * 2002-08-27 2004-06-10 Larry Rigby Methods and apparatus for transdermal delivery of abusable drugs with a deterrent agent
WO2004062600A2 (fr) * 2003-01-08 2004-07-29 Lectec Corporation Patch antiviral
US20040228802A1 (en) * 2003-05-12 2004-11-18 Rong-Kun Chang Drug formulations having reduced abuse potential

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11844763B2 (en) 2014-04-17 2023-12-19 Avenir Wellness Solutions, Inc. Pharmaceutical composition and method of manufacturing

Also Published As

Publication number Publication date
WO2008133982A2 (fr) 2008-11-06

Similar Documents

Publication Publication Date Title
WO2008133982A3 (fr) Timbre adhésif contenant un agent aversif
MY164418A (en) Adhesive patch
WO2010060937A3 (fr) Combinaisons inhibitrices hsp90
EP2177217A4 (fr) Composition comprenant de la rotigotine, son utilisation et timbre transdermique comprenant la composition
WO2007120747A3 (fr) Méthodes et systèmes transdermiques d'administration de composés anti-migraine
WO2009089494A3 (fr) Compositions pharmaceutiques
CA117120S (en) Coating material dispensing device
WO2009097508A3 (fr) Procédés et compositions pour la cicatrisation
WO2008057780A3 (fr) Administration transdermique de dérivés polaires de kétoprofène
WO2012034079A3 (fr) Formes pharmaceutiques de type macrolides
WO2009031068A3 (fr) Articles absorbants portables à jeter avec sous-systèmes de fixation
WO2009031070A3 (fr) Articles absorbants portables à jeter avec sous-systèmes de fixation
WO2009031069A3 (fr) Articles absorbants portables à jeter avec sous-systèmes de fixation
EP1995282A4 (fr) Couche viscoelastique renfermant des microparticules et bande ou feuille adhesive sensible a la pression
WO2008090555A3 (fr) Dispositifs médicaux dotés d'une matrice adhérant à ceux-ci
EP2267090B8 (fr) Film adhésif et procédé d'amincissement de plaquette utilisant ledit film
PT2168608E (pt) Fita ou folha adesiva sensível à pressão para aplicar sobre a pele, e processo para a sua produção
WO2011088333A3 (fr) Formulations pour anesthésie locale se solidifiant pour la gestion de la douleur
WO2011088072A3 (fr) Dispositif de délivrance dermique
WO2009156182A3 (fr) Dérivés de l'uracile et leur utilisation
WO2011029948A3 (fr) Système thérapeutique transdermique pour l'administration de fentanyle ou d'un analogue du fentanyle
WO2007084753A3 (fr) Article nettoyant pour la peau
WO2009085890A3 (fr) Dispositif médical cutané avec adhésif ultra-hydrophile sensible à la pression
WO2008104720A3 (fr) Patch pour application cutanee
AU2008303948A8 (en) Use of the peptide Asn-Asp-Asp-Cys-Glu- Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu alone or in combination with the peptide Thr-Thr-Ser-Gln-Val- Arg-Pro-Arg as a therapeutic agent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08743286

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08743286

Country of ref document: EP

Kind code of ref document: A2